Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: retrospective study

被引：53
作者：
Svensson, M
Gustafsson, F
Galatius, S
Hildebrandt, PR
Atar, D [1 ]
机构：
[1] Aker Univ Hosp, Div Cardiol, Oslo, Norway
[2] Frederiksberg Univ Hosp, Dept Cardiol & Endocrinol, DK-2000 Copenhagen, Denmark
来源：
BRITISH MEDICAL JOURNAL | 2003年 / 327卷 / 7424期
关键词：
D O I：
10.1136/bmj.327.7424.1141
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1141 / 1142
页数：2
相关论文
共 5 条
[1]  
GALATIUS S, 2002, AM HEART J S, V144, pS2
[2]  
GREENBERG B, 2002, J CARDIOVASC PHARM, V38, P59
[3]   Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction [J].
Pitt, B ;
Remme, W ;
Zannad, F ;
Neaton, J ;
Martinez, F ;
Roniker, B ;
Bittman, R ;
Hurley, S ;
Kleiman, J ;
Gatlin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) :1309-1321
[4]   The effect of spironolactone on morbidity and mortality in patients with severe heart failure [J].
Pitt, B ;
Zannad, F ;
Remme, WJ ;
Cody, R ;
Castaigne, A ;
Perez, A ;
Palensky, J ;
Wittes, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) :709-717
[5]   Comprehensive guidelines for the diagnosis and treatment of chronic heart failure - Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology [J].
Remme, WJ ;
Swedberg, K .
EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (01) :11-22
1